Effect of intestinal microbiome, antibiotics, and probiotics in
the prevention and management of ulcerative colitis

C 2022

Effect of intestinal microbiome, antibiotics, and probiotics in the prevention and management of ulcerative colitis

KUSHKEVYCH, Ivan and Josef JAMPÍLEK

Basic information

Original name

Effect of intestinal microbiome, antibiotics, and probiotics in the prevention and management of ulcerative colitis

Authors

KUSHKEVYCH, Ivan (203 Czech Republic, guarantor, belonging to the institution) and Josef JAMPÍLEK

Edition

Cambridge, Probiotics in the Prevention and Management of Human Diseases : A Scientific Perspective, p. 59-92, 34 pp. 2022

Publisher

Elsevier

Other information

Language

English

Type of outcome

Kapitola resp. kapitoly v odborné knize

Field of Study

10606 Microbiology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Publication form

printed version "print"

References:

URL

RIV identification code

RIV/00216224:14310/22:00125081

Organization unit

Faculty of Science

ISBN

978-0-12-823733-5

DOI

http://dx.doi.org/10.1016/B978-0-12-823733-5.00016-7

Keywords in English

Intestinal microbiota; sulfate-reducing bacteria; hydrogen sulfide; bowel diseases; ulcerative colitis; probiotics; prebiotics

Abstract

V originále

More and more people suffer from a variety of chronic inflammatory diseases, which are mainly caused by stress and a deteriorating environment. Chronic inflammatory bowel diseases are one of the most common such diseases. Their treatment is problematic and lengthy, and in fact, patients are never really cured. In addition, these diseases are associated with a number of other intestinal problems. The intestinal microbiome is a great help in the fight against these chronic diseases. This chapter summarizes current literature data on the role of microbiota in the development of human colon diseases. Special attention is paid to the involvement of sulfate- reducing bacteria in the development of ulcerative colitis. They are characterized by methods of molecular hydrogen metabolism by sulfate-reducing bacteria in the intestine. The influence and mechanism of action of the main product of metabolism of these microorganisms—hydrogen sulfide—on cells is described. The properties of antimicrobial drugs used in intestinal diseases are presented, and the importance of probiotics for the prevention and treatment of intestinal diseases is described.

Links

MUNI/A/1425/2020, interní kód MU

Name: Podpora výzkumné činnosti studentů Mikrobiologie

Investor: Masaryk University

Citovat

KUSHKEVYCH, Ivan and Josef JAMPÍLEK. Effect of intestinal microbiome, antibiotics, and probiotics in the prevention and management of ulcerative colitis. In Mitesh Kumar Dwivedi; N. Amaresan; A. Sankaranarayanan; E. Helen Kemp. Probiotics in the Prevention and Management of Human Diseases : A Scientific Perspective. Cambridge: Elsevier, 2022, p. 59-92. ISBN 978-0-12-823733-5. Available from: https://dx.doi.org/10.1016/B978-0-12-823733-5.00016-7.

@inbook{1807770,
   author = {Kushkevych, Ivan and Jampílek, Josef},
   address = {Cambridge},
   booktitle = {Probiotics in the Prevention and Management of Human Diseases : A Scientific Perspective},
   doi = {http://dx.doi.org/10.1016/B978-0-12-823733-5.00016-7},
   editor = {Mitesh Kumar Dwivedi; N. Amaresan; A. Sankaranarayanan; E. Helen Kemp},
   keywords = {Intestinal microbiota; sulfate-reducing bacteria; hydrogen sulfide; bowel diseases; ulcerative colitis; probiotics; prebiotics},
   howpublished = {tištěná verze "print"},
   language = {eng},
   location = {Cambridge},
   isbn = {978-0-12-823733-5},
   pages = {59-92},
   publisher = {Elsevier},
   title = {Effect of intestinal microbiome, antibiotics, and probiotics in the prevention and management of ulcerative colitis},
   url = {https://www.sciencedirect.com/science/article/pii/B9780128237335000167},
   year = {2022}
}

TY  - CHAP
ID  - 1807770
AU  - Kushkevych, Ivan - Jampílek, Josef
PY  - 2022
TI  - Effect of intestinal microbiome, antibiotics, and probiotics in the prevention and management of ulcerative colitis
VL  - Neuveden
PB  - Elsevier
CY  - Cambridge
SN  - 9780128237335
KW  - Intestinal microbiota
KW  - sulfate-reducing bacteria
KW  - hydrogen sulfide
KW  - bowel diseases
KW  - ulcerative colitis
KW  - probiotics
KW  - prebiotics
UR  - https://www.sciencedirect.com/science/article/pii/B9780128237335000167
N2  - More and more people suffer from a variety of chronic inflammatory diseases, which are mainly caused by stress and a deteriorating environment. Chronic inflammatory bowel diseases are one of the most common such diseases. Their treatment is problematic and lengthy, and in fact, patients are never really cured. In addition, these diseases are associated with a number of other intestinal problems. The intestinal microbiome is a great help in the fight against these chronic diseases. This chapter summarizes current literature data on the role of microbiota in the development of human colon diseases. Special attention is paid to the involvement of sulfate- reducing bacteria in the development of ulcerative colitis. They are characterized by methods of molecular hydrogen metabolism by sulfate-reducing bacteria in the intestine. The influence and mechanism of action of the main product of metabolism of these microorganisms—hydrogen sulfide—on cells is described. The properties of antimicrobial drugs used in intestinal diseases are presented, and the importance of probiotics for the prevention and treatment of intestinal diseases is described.
ER  -

KUSHKEVYCH, Ivan and Josef JAMPÍLEK. Effect of intestinal microbiome, antibiotics, and probiotics in the prevention and management of ulcerative colitis. In Mitesh Kumar Dwivedi; N. Amaresan; A. Sankaranarayanan; E. Helen Kemp. \textit{Probiotics in the Prevention and Management of Human Diseases : A Scientific Perspective}. Cambridge: Elsevier, 2022, p.~59-92. ISBN~978-0-12-823733-5. Available from: https://dx.doi.org/10.1016/B978-0-12-823733-5.00016-7.

Detailed Information on Publication Record